Skip to main content
رجوع
WUXIF logo

WuXi AppTec Co., Ltd.

جودة البيانات: 100%
ذروة بيع
WUXIF
OTC Healthcare Medical - Diagnostics & Research
KWD 13.88
KWD 0.00 (0.00%)
القيمة السوقية: 41.41B
مُدرج أيضًا باسم WUXAY OTC
نطاق اليوم
KWD 13.88 KWD 15.00
نطاق 52 أسبوعًا
KWD 7.34 KWD 16.80
حجم التداول
600
متوسط 50 يوم / 200 يوم
KWD 14.12 / KWD 12.83
الإغلاق السابق
KWD 13.88

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (626 نظير)

المقياس السهم وسيط القطاع
P/E 4.4 0.4
P/B 0.7 2.9
ROE % 16.6 3.7
Net Margin % 24.1 3.9
Rev Growth 5Y % 24.1 10.0
D/E 0.1 0.2

السعر المستهدف للمحللين

لا تتوفر تغطية محللين

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2028 KWD 7.377
KWD 6.898 – KWD 8.039
 68 B 1
FY2027 KWD 6.429
KWD 6.011 – KWD 7.006
 59 B 1
FY2026 KWD 5.601
KWD 5.237 – KWD 6.104
 52 B 1

النقاط الرئيسية

Revenue grew 24.12% annually over 5 years — strong growth
ROE of 16.62% — decent returns on equity
Net margin of 24.08% shows strong profitability
Debt/Equity of 0.08 — conservative balance sheet
Generating 8.40B in free cash flow
P/E of 4.38 — trading at a low valuation

النمو

Revenue Growth (5Y)
24.12%
Revenue (1Y)-2.73%
Earnings (1Y)-1.63%
FCF Growth (3Y)259.46%

الجودة

Return on Equity
16.62%
ROIC13.70%
Net Margin24.08%
Op. Margin29.51%

الأمان

Debt / Equity
0.08
Current Ratio2.38
Interest Coverage53.60

التقييم

P/E Ratio
4.38
P/B Ratio0.71
EV/EBITDA2.40
Dividend Yield0.02%

All Fundamental Metrics

Growth
Revenue Growth (1Y) -2.73% Revenue Growth (3Y) -0.14%
Earnings Growth (1Y) -1.63% Earnings Growth (3Y) 3.55%
Revenue Growth (5Y) 24.12% Earnings Growth (5Y) 33.67%
Profitability
Revenue (TTM) 39.24B Net Income (TTM) 9.45B
ROE 16.62% ROA 11.76%
Gross Margin 41.48% Operating Margin 29.51%
Net Margin 24.08% Free Cash Flow (TTM) 8.40B
ROIC 13.70% FCF Growth (3Y) 259.46%
Safety
Debt / Equity 0.08 Current Ratio 2.38
Interest Coverage 53.60 Dividend Yield 0.02%
Valuation
P/E Ratio 4.38 P/B Ratio 0.71
P/S Ratio 1.06 PEG Ratio 12.27
EV/EBITDA 2.40 Dividend Yield 0.02%
Market Cap 41.41B Enterprise Value 27.84B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 39.24B 40.34B 39.35B 22.90B 16.54B
Net Income 9.45B 9.61B 8.81B 5.10B 2.96B
EPS (Diluted) 3.26 3.24 2.82 1.73 1.05
Gross Profit 16.28B 16.57B 14.68B 8.31B 6.28B
Operating Income 11.58B 11.87B 10.65B 6.04B 3.39B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 80.33B 73.67B 64.69B 55.13B 46.29B
Total Liabilities 21.24B 18.15B 17.76B 16.37B 13.57B
Shareholders' Equity 58.63B 55.12B 46.59B 38.49B 32.49B
Total Debt 4.75B 5.45B 5.87B 4.28B 4.29B
Cash & Equivalents 18.32B 13.76B 7.99B 8.24B 10.24B
Current Assets 38.69B 30.42B 24.00B 21.99B 23.06B
Current Liabilities 16.23B 14.76B 14.50B 12.98B 7.92B

درجات الاستراتيجيات

This stock passed the criteria for 3 strategies

Score = fit strength (0–100)
Rank = position among all matches
Custom Deep Value Investing (Seth Klarman)
#104 of 820
63
Custom Contrarian Investing (David Dreman)
#239 of 658
39
Value Defensive Investing (Benjamin Graham)
#75 of 708
59

النشاط الأخير

دخل Deep Value Investing (Seth Klarman)
Mar 24, 2026
دخل Contrarian Investing (David Dreman)
Mar 24, 2026
دخل Defensive Investing (Benjamin Graham)
Mar 24, 2026